L. Hansen Carl - Jun 9, 2021 Form 4 Insider Report for AbCellera Biologics Inc. (ABCL)

Role
Chief Executive Officer, Director, 10%+ Owner
Signature
/s/ Tryn Stimart, attorney-in-fact
Stock symbol
ABCL
Transactions as of
Jun 9, 2021
Transactions value $
-$144,770,323
Form type
4
Date filed
6/10/2021, 05:11 PM
Next filing
Nov 22, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ABCL Common Shares Sale -$135M -5.6M -9.15% $24.03 55.6M Jun 9, 2021 See Footnote F1, F2
transaction ABCL Common Shares Sale -$10.2M -402K -63.23% $25.50 234K Jun 9, 2021 See Footnote F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On June 9, 2021, the shares were sold in connection with a private sale transaction at a per share price of $24.03.
F2 These shares are held by Thermopylae Holdings Ltd., which is an entity wholly owned by the Reporting Person.
F3 On June 9, 2021, the shares were sold in connection with a private sale transaction at a per share price of $25.50.
F4 These shares are held by Hankla Family Trust (2019), of which the Reporting Person and his spouse are joint trustees. The Reporting Person disclaims beneficial ownership of such securities, except to the extent of his indirect pecuniary interest therein.